NP
MDT icon

Nilsine Partners’s Medtronic MDT Stock Holding History

Nilsine Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,980
Closed -$286K – 457
2025
Q4 		$286K Buy
2,980
+23
+0.8% +$2.23K 0.02% 335
2025
Q3 		$282K Sell
2,957
-433
-13% -$39.8K 0.03% 338
2025
Q2 		$296K Buy
3,390
+187
+6% +$15.9K 0.03% 317
2025
Q1 		$288K Buy
3,203
+194
+6% +$17.4K 0.03% 306
2024
Q4 		$240K Buy
+3,009
New +$260K 0.03% 339
2023
Q3 		– Sell
-2,892
Closed -$255K – 366
2023
Q2 		$255K Sell
2,892
-122
-4% -$10.5K 0.04% 305
2023
Q1 		$243K Buy
+3,014
New +$246K 0.04% 305

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nilsine Partners's MDT Position: Q1 2026 in Review

Nilsine Partners sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,980 shares — an estimated $286K sold.

Nilsine Partners first reported a position in MDT in Q1 2023 and held it in 7 quarters. The position peaked at $296K in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Nilsine Partners reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Nilsine Partners sold 2,980 Medtronic shares in Q1 2026, an estimated $286K.
  • Nilsine Partners first reported a position in Medtronic in Q1 2023 and held it in 7 quarters.
  • Nilsine Partners's Medtronic position peaked at $296K in Q2 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Nilsine Partners's 13F filing for Q1 2026, filed 29 Apr 2026.